# Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia

> **NCT00477490** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 799 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** desmopressin acetate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00477490
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 799 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477490, "Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00477490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*